Skip Navigation LinksHome > November 2012 - Volume 5 - Issue 11 > Clinical Trial Alert
Text sizing:
A
A
A
Nephrology Times:
doi: 10.1097/01.NEP.0000424005.47261.e0
Clinical Trial Alert

Clinical Trial Alert

Free Access

The following is a partial list of new clinical trials recently added to the National Institutes of Health's ClinicalTrials.gov online registry. More information on these trials is available at www.clinicaltrials.gov.

Back to Top | Article Outline

• Anemia •

NCT01690455

An Observational Study of Mircera in Renal Anemia Correction in Dialyzed Patients During Daily Clinical Practice

Ages eligible for study: 18 years and older

Sponsors and collaborators: Hoffmann-La Roche

Contact: Reference Study ID Number: ML25701

Phone: 888-662-6728

Back to Top | Article Outline
NCT01695746

An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Stage III-IV Chronic Kidney Disease Patients Not on Dialysis with Renal Anemia

Ages eligible for study: 18 years to 65 years

Sponsors and collaborators: Hoffmann-La Roche

Contact: Reference Study ID Number: ML25476

Phone: 888-662-6728

Back to Top | Article Outline
NCT01695759

Evaluation of Clinical Efficacy and Immunogenicity of Eritromax, Produced by Lab Blau Pharmaceutical S/A, Compared to the Product Eprex, Produced by the Laboratory Janssen-Cilag, in Patients with Anemia Secondary to Chronic Kidney Disease

Ages eligible for study: 18 years to 60 years

Sponsors and collaborators: LAL Clinica Pesquisa e Desenvolvimento Ltda. (LAL Research and Development Clinic)

Contact: Alexandre Frederico

Phone: (19) 38716399

E-mail: alexandre@lalclinica.com.br

Back to Top | Article Outline
NCT01693029

Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa (ACCESS)

Ages eligible for study: 18 years and older

Sponsors and collaborators: Sandoz

Contact: Sandoz Biopharmaceuticals

Phone: +49-8024-476-0

Back to Top | Article Outline

• Chronic Kidney Disease–Mineral and Bone Disorder •

NCT01696279

A Comparison of Lanthanum Carbonate and Calcium Carbonate in Children

Ages eligible for study: 6 months to 17 years

Sponsors and collaborators: Shire Development LLC

Contact: Shire Call Center

Phone: 866-842-5335

Back to Top | Article Outline
NCT01694160

Oral Paricalcitol in Renal Transplant Recipients for Reducing Albuminuria

Ages eligible for study: 18 years to 70 years

Sponsors and collaborators: Oslo University Hospital

Contact: Hallvard Holdaas, MD, PhD

Phone: 472-307-1247

E-mail: hallvard.holdaas@oslo-universitetssykehus.no

Back to Top | Article Outline

• Diabetes •

NCT01683409

A Study to Test Safety and Efficacy of Baricitinib in Participants with Diabetic Kidney Disease

Ages eligible for study: 18 years and older

Sponsors and collaborators: Eli Lilly and Company, Incyte Corporation

Contact: Eli Lilly and Company

Phone: 877-285-4559

Back to Top | Article Outline

• End-Stage Renal Disease •

NCT01691196

Inflammation in Peritoneal Dialysis Patients: Effect of Obesity

Ages eligible for study: 18 years and older

Sponsors and collaborators: University of Illinois

Contact: Natalia Litbarg, MD

Phone: 312-996-7378

E-mail: nlitbarg@uic.edu

Contact: Giamila Fantuzzi, PhD

Phone: 312-413-5398

E-mail: giamila@uic.edu

Back to Top | Article Outline
NCT01691053

Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease (MiREnDa)

Ages eligible for study: 18 years and older

Sponsors and collaborators: Wuerzburg University Hospital, German Federal Ministry of Education and Research, Clinical Trial Center Wuerzburg (CTCW)

Contact: Fabian Hammer, MD, PhD

Phone: +49931201, ext. 46380

E-mail: hammer_f@klinik.uni-wuerzburg.de

Contact: Christoph Wanner, MD

Phone: +49931201, ext. 39030

E-mail: wanner_c@klinik.uni-wuerzburg.de

Back to Top | Article Outline
NCT01693354

Mid-HDF Randomized Controlled Study on Outcome

Ages eligible for study: 18 years to 85 years

Sponsors and collaborators: Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi

Contact: Antonio Santoro, MD

Phone: +39 0516362430

E-mail: antonio.santoro@aosp.bo.it

Back to Top | Article Outline

• Hypertension •

NCT01689415

Renal Denervation Hypertension After Stroke (REHEARSE)

Ages eligible for study: 18 years and older

Sponsors and collaborators: Bispebjerg Hospital; Rigshospitalet, Denmark

Contact: Hanne Christensen, MD, PhD, DMSci

Phone: 0045 35312754

E-mail: hanne.krarup.christensen@regionh.dk

Contact: Line Bentsen

Phone: 0045 61143723

E-mail: line.bentsen@regionh.dk

Back to Top | Article Outline
NCT01687725

Renal Denervation in Treatment-Resistant Hypertension

Ages eligible for study: 18 years to 85 years

Sponsors and collaborators: University of Erlangen–Nuremberg Medical School

Contact: Christian Ott, MD

Phone: 0049-9131-85, ext. 36245

E-mail: christian.ott@uk-erlangen.de

Back to Top | Article Outline
NCT01704170

Feasibility Study to Evaluate Renal Denervation Using Focused Ultrasound

Ages eligible for study: 18 years and older

Sponsors and collaborators: Kona Medical Inc.

Contact: Stephanie Higie

E-mail: shigie@konamedical.com

Back to Top | Article Outline

• Membranous Nephropathy •

NCT01180036

Membranous Nephropathy Trial of Rituximab (MENTOR)

Ages eligible for study: 18 years to 80 years

Sponsors and collaborators: Mayo Clinic

Contact: Mayo Collaborative Group Study Desk

Phone: 507-266-1047 or 507-255-0231

E-mail: mncg@mayo.edu

Back to Top | Article Outline

• Transplantation •

NCT01686191

Genetic Predictors of Renal Function Following Heart Transplantation

Ages eligible for study: 18 years to 90 years

Sponsors and collaborators: University of Colorado, Denver; National Jewish Health

Contact: Christina L Aquilante, PharmD

Phone: 303-724-6126

E-mail: christina.aquilante@ucdenver.edu

Back to Top | Article Outline
NCT01689272

Functional Reserve Estimation of Donor Kidney

Ages eligible for study: 18 years to 60 years

Sponsors and collaborators: Republican Scientific Center for Emergency Medicine

Contact: Gani M. Kuttymuratov, PhD

Phone: +77172702912, ext. +77018812206

E-mail: aiger2000@mail.ru

Contact: Kuat P. Oshakbayev, PhD, DSc

Phone: +77172702905, ext. +77013999394

E-mail: okp.kuat@mail.ru

Back to Top | Article Outline
NCT01709097

Compliance/Adherence After Kidney Transplant, With or Without Med-O-Wheel

Sponsors and collaborators: Karolinska University Hospital, Addoz, Roche Pharma AG, Tele2 Sverige AB

Contact: Jarmo Henriksson, RN

Phone: +46 8 585 825 64

E-mail: jarmo.henriksson@karolinska.se

Back to Top | Article Outline
NCT01706471

Safety and Efficacy of the Early Introduction of Everolimus (Certican) With Low Dose of Cyclosporine in de Novo Kidney Recipients After 1 Month of Transplantation

Ages eligible for study: 18 years to 65 years

Sponsors and collaborators: Yonsei University

Contact: Yu Seun Kim, MD

Phone: +82-2-2228-2115

E-mail: yukim@yuhs.ac

Back to Top | Article Outline

• Miscellaneous •

NCT01674465

The Role of Nox2 in CNI-Induced Renal Fibrosis

Ages eligible for study: 18 years to 70 years

Sponsors and collaborators: University of Wisconsin–Madison

Contact: Lynn M. Jacobson

Phone: 608-265-5489

E-mail: lmj@medicine.wisc.edu

Contact: Arjang Djamali, MD, MS

Phone: 608-265-7593

E-mail: axd@medicine.wisc.edu

© 2012 Lippincott Williams & Wilkins, Inc.

Login